ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
|
GSK plc announced that ViiV Healthcare, the global
specialist HIV company majority owned by GSK, with Pfizer and Shionogi
as shareholders, has shared ... |